Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus.
about
Primary medication non-adherence: analysis of 195,930 electronic prescriptionsEffectiveness of disease-management programs for improving diabetes care: a meta-analysisPoor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributorsPharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agentsMultimorbidity and Patient Safety Incidents in Primary Care: A Systematic Review and Meta-AnalysisThe effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysisEffect of drug reminder packaging on medication adherence: a systematic review revealing research gapsIs adherence a relevant issue in the self-management education of diabetes? A mixed narrative reviewClinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combinationMedicaid prescription limits: policy trends and comparative impact on utilization.Potential workload in applying clinical practice guidelines for patients with chronic conditions and multimorbidity: a systematic analysisDefining the role of medication adherence in poor glycemic control among a general adult population with diabetesCost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in ChinaEffect of switching to a high-deductible health plan on use of chronic medicationsAdherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin.Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden.Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions.Ultrasound detection of increased carotid intima-media thickness and carotid plaque in an office practice setting: does it affect physician behavior or patient motivation?Adherence to sleep apnea therapy and use of lipid-lowering drugs: a study of the healthy-user effectFactors that lessen the burden of treatment in complex patients with chronic conditions: a qualitative study.Multidrug punch cards in primary care: a mixed methods study on patients' preferences and impact on adherence.Factors affecting medication adherence: patient perspectives from five veterans affairs facilities.Missing signposts on the roadmap to quality: a call to improve medication adherence indicators in data collection for population researchUse of pharmacy dispensing data to measure adherence and identify nonadherence with oral hypoglycemic agents.Development and feasibility of a text messaging and interactive voice response intervention for low-income, diverse adults with type 2 diabetes mellitusAdherence to evidence-based guidelines among diabetes self-management apps.Medication adherence and persistence in type 2 diabetes mellitus: perspectives of patients, physicians and pharmacists on the Spanish health care systemDiscordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by Physicians.Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes.Effects of miglitol taken just before or after breakfast on plasma glucose, serum insulin, glucagon and incretin levels after lunch in men with normal glucose tolerance, impaired fasting glucose or impaired glucose tolerance.Results of a pilot study of patient-to-patient education strategy on self-management among glycemic uncontrolled patients with diabetesAssociation between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees.Evaluation of the chronic disease management program for appropriateness of medication adherence and persistence in hypertension and type-2 diabetes patients in Korea.Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes.Medicare Part D coverage gap and diabetes beneficiaries.Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-AnalysisHigh-risk diabetic patients in Medicare Part D programs: are they getting the recommended ACEI/ARB therapy?Medications Adherence and Associated Factors among Patients with Type 2 Diabetes Mellitus in the Gaza Strip, Palestine.Early discontinuation and restart of insulin in the treatment of type 2 diabetes mellitus
P2860
Q24619145-95DA9C12-7AF9-4BD7-A178-D7C8D93AAE5EQ24630481-F4C06B03-6EBA-42D4-87D1-E9392CD6D2B9Q26741537-9C4B3417-6E36-4224-AE8F-AE9641F7FA60Q26751138-FEB3A2EE-88AE-4350-9E4E-63C0A3D13AFEQ26796372-3F1F37E6-F221-4A74-897C-3A0C93AA82A1Q26829072-90205112-85EC-4340-8EB9-C9B6598DCFA4Q26862555-8CFA23F2-4C8C-4265-AC00-364EDE84AB0DQ27008203-B52C019C-6A1E-4052-A2C4-18BD643F598AQ27026211-A3BC4AEE-4B07-4203-9A69-DFAF3A94E4B8Q27306989-58B3F304-DF5A-4FC0-B45E-CE7CA3EC6929Q28079905-A989B11C-545C-4E4D-B874-23B3B7CD322DQ28543287-1EF13CB2-E1B0-4046-9680-6958CB1FACF7Q28553675-B31159DA-7375-486F-BF79-053DFAF2F87DQ28743191-C2570AD6-63FB-4C50-9F22-F786286BAC1BQ30248710-8BFEEC19-C573-40A7-9643-9AE1FC2ECFC0Q30276056-7B8E0E97-62C3-424C-833C-ECCE31B970CFQ30300229-9D301DD3-EE9C-4B2F-953E-0E321B1AE9AAQ30370535-BC10CFDC-6519-48B2-9497-7BE0C97BA33EQ30492680-7DF2D1DA-0D53-4BBA-AD3D-9A1053B9B65BQ30574599-06A91EF8-3708-4628-98B4-508EBF1CD76BQ30588645-C5C63736-4380-4088-8F61-36B555AF35ACQ30600372-6E8A9639-1DE0-471D-AF80-952E80CD390FQ30694151-E23D8317-7863-46B2-8DD9-4216277CE9EFQ31139994-CA09C64E-39BE-42B5-8649-F2BCA307459FQ33439766-C6DD918B-48A0-46E2-9499-DC5174F4A4E0Q33440063-27850EF7-8941-4143-BC6C-2099EC37733CQ33553710-DC65746A-D4D1-45DF-8899-74B39C97F274Q33572182-B691E4FE-A2C2-4535-9D40-75215DE5F59FQ33573537-1E4662EA-1133-42F1-B8EA-6CDAC93516ABQ33585555-FC5DF0BB-B2A5-4972-A08B-230458A79A75Q33596403-3E996D5E-218C-4923-ACB2-AD01C4CFB8AEQ33610927-67245457-CABF-4301-A338-63513F19DA1AQ33621412-99C0E5B3-A51B-4E7A-A8F1-A6F9893C7B4CQ33652884-90DD36EE-3FAE-4655-B31B-1EBDBD446F1CQ33667931-63642E0A-19AE-4754-83F6-0E071C6BB61EQ33707663-072832FB-88F8-47E6-A2C8-873B98967E31Q33732649-44C70B4D-7FE0-4C7E-B38E-FBED42AE2BB5Q33742516-6B20F96D-ABD4-4327-8163-A64546D6D6B0Q33780676-1E713012-414E-4415-B92B-7F0EE7077D1FQ33785208-8D111063-A1F6-4627-BCD7-B0097C57F829
P2860
Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Effect of medication nonadhere ...... tients with diabetes mellitus.
@en
Effect of medication nonadhere ...... tients with diabetes mellitus.
@nl
type
label
Effect of medication nonadhere ...... tients with diabetes mellitus.
@en
Effect of medication nonadhere ...... tients with diabetes mellitus.
@nl
prefLabel
Effect of medication nonadhere ...... tients with diabetes mellitus.
@en
Effect of medication nonadhere ...... tients with diabetes mellitus.
@nl
P2093
P1476
Effect of medication nonadhere ...... tients with diabetes mellitus.
@en
P2093
David J Magid
David L McClure
John F Steiner
John S Rumsfeld
Mary E Plomondon
P Michael Ho
P304
P356
10.1001/ARCHINTE.166.17.1836
P407
P577
2006-09-01T00:00:00Z